The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Lenvatinib Market Research Report 2024

Global Lenvatinib Market Research Report 2024

Publishing Date : Feb, 2021

License Type :
 

Report Code : 1619806

No of Pages : 94

Synopsis
Lenvatinib (trade name Lenvima) is an anti-cancer drug for the treatment of certain kinds of thyroid cancer and for other cancers as well. It was developed by Eisai Co. and acts as a multiple kinase inhibitor against the VEGFR1, VEGFR2 and VEGFR3 kinases.

The global Lenvatinib market was valued at US$ XX million in 2019 and is expected to reach US$ XX million by the end of 2026, growing at a CAGR of XX% during 2021-2026.
This report focuses on Lenvatinib volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Lenvatinib market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Lenvatinib Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
4mg
10mg

Segment by Application
Hospital
Pharmacy
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Eisai Co.
Beacon Pharmaceuticals Limited
Shilpa Medicare Ltd.
Everest Medicines
Index
1 Lenvatinib Market Overview
1.1 Product Overview and Scope of Lenvatinib
1.2 Lenvatinib Segment by Type
1.2.1 Global Lenvatinib Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 4mg
1.2.3 10mg
1.3 Lenvatinib Segment by Application
1.3.1 Lenvatinib Sales Comparison by Application: (2021-2027)
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Other
1.4 Global Lenvatinib Market Size Estimates and Forecasts
1.4.1 Global Lenvatinib Revenue 2016-2027
1.4.2 Global Lenvatinib Sales 2016-2027
1.4.3 Lenvatinib Market Size by Region: 2016 Versus 2021 Versus 2027

2 Lenvatinib Market Competition by Manufacturers
2.1 Global Lenvatinib Sales Market Share by Manufacturers (2016-2021)
2.2 Global Lenvatinib Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Lenvatinib Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Lenvatinib Manufacturing Sites, Area Served, Product Type
2.5 Lenvatinib Market Competitive Situation and Trends
2.5.1 Lenvatinib Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Lenvatinib Players Market Share by Revenue
2.5.3 Global Lenvatinib Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Lenvatinib Retrospective Market Scenario by Region
3.1 Global Lenvatinib Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Lenvatinib Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Lenvatinib Market Facts & Figures by Country
3.3.1 North America Lenvatinib Sales by Country
3.3.2 North America Lenvatinib Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Lenvatinib Market Facts & Figures by Country
3.4.1 Europe Lenvatinib Sales by Country
3.4.2 Europe Lenvatinib Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Lenvatinib Market Facts & Figures by Region
3.5.1 Asia Pacific Lenvatinib Sales by Region
3.5.2 Asia Pacific Lenvatinib Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Lenvatinib Market Facts & Figures by Country
3.6.1 Latin America Lenvatinib Sales by Country
3.6.2 Latin America Lenvatinib Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Lenvatinib Market Facts & Figures by Country
3.7.1 Middle East and Africa Lenvatinib Sales by Country
3.7.2 Middle East and Africa Lenvatinib Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Lenvatinib Historic Market Analysis by Type
4.1 Global Lenvatinib Sales Market Share by Type (2016-2021)
4.2 Global Lenvatinib Revenue Market Share by Type (2016-2021)
4.3 Global Lenvatinib Price by Type (2016-2021)

5 Global Lenvatinib Historic Market Analysis by Application
5.1 Global Lenvatinib Sales Market Share by Application (2016-2021)
5.2 Global Lenvatinib Revenue Market Share by Application (2016-2021)
5.3 Global Lenvatinib Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Eisai Co.
6.1.1 Eisai Co. Corporation Information
6.1.2 Eisai Co. Description and Business Overview
6.1.3 Eisai Co. Lenvatinib Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Eisai Co. Product Portfolio
6.1.5 Eisai Co. Recent Developments/Updates
6.2 Beacon Pharmaceuticals Limited
6.2.1 Beacon Pharmaceuticals Limited Corporation Information
6.2.2 Beacon Pharmaceuticals Limited Description and Business Overview
6.2.3 Beacon Pharmaceuticals Limited Lenvatinib Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Beacon Pharmaceuticals Limited Product Portfolio
6.2.5 Beacon Pharmaceuticals Limited Recent Developments/Updates
6.3 Shilpa Medicare Ltd.
6.3.1 Shilpa Medicare Ltd. Corporation Information
6.3.2 Shilpa Medicare Ltd. Description and Business Overview
6.3.3 Shilpa Medicare Ltd. Lenvatinib Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Shilpa Medicare Ltd. Product Portfolio
6.3.5 Shilpa Medicare Ltd. Recent Developments/Updates
6.4 Everest Medicines
6.4.1 Everest Medicines Corporation Information
6.4.2 Everest Medicines Description and Business Overview
6.4.3 Everest Medicines Lenvatinib Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Everest Medicines Product Portfolio
6.4.5 Everest Medicines Recent Developments/Updates

7 Lenvatinib Manufacturing Cost Analysis
7.1 Lenvatinib Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Lenvatinib
7.4 Lenvatinib Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Lenvatinib Distributors List
8.3 Lenvatinib Customers

9 Lenvatinib Market Dynamics
9.1 Lenvatinib Industry Trends
9.2 Lenvatinib Growth Drivers
9.3 Lenvatinib Market Challenges
9.4 Lenvatinib Market Restraints

10 Global Market Forecast
10.1 Lenvatinib Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Lenvatinib by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Lenvatinib by Type (2022-2027)
10.2 Lenvatinib Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Lenvatinib by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Lenvatinib by Application (2022-2027)
10.3 Lenvatinib Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Lenvatinib by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Lenvatinib by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
List of Tables
Table 1. Global Lenvatinib Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Lenvatinib Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Lenvatinib Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Lenvatinib Covered in This Study
Table 5. Global Lenvatinib Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Lenvatinib Sales Share by Manufacturers (2016-2021)
Table 7. Global Lenvatinib Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Lenvatinib Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Lenvatinib Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Lenvatinib Manufacturing Sites and Area Served
Table 11. Manufacturers Lenvatinib Product Type
Table 12. Global Lenvatinib Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Lenvatinib by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lenvatinib as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Lenvatinib Sales by Region (2016-2021) & (K Units)
Table 16. Global Lenvatinib Sales Market Share by Region (2016-2021)
Table 17. Global Lenvatinib Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Lenvatinib Sales by Country (2016-2021) & (K Units)
Table 19. North America Lenvatinib Sales Market Share by Country (2016-2021)
Table 20. North America Lenvatinib Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Lenvatinib Revenue Market Share by Country (2016-2021)
Table 22. Europe Lenvatinib Sales by Country (2016-2021) & (K Units)
Table 23. Europe Lenvatinib Sales Market Share by Country (2016-2021)
Table 24. Europe Lenvatinib Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Lenvatinib Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Lenvatinib Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Lenvatinib Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Lenvatinib Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Lenvatinib Revenue Market Share by Region (2016-2021)
Table 30. Latin America Lenvatinib Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Lenvatinib Sales Market Share by Country (2016-2021)
Table 32. Latin America Lenvatinib Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Lenvatinib Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Lenvatinib Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Lenvatinib Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Lenvatinib Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Lenvatinib Revenue Market Share by Country (2016-2021)
Table 38. Global Lenvatinib Sales (K Units) by Type (2016-2021)
Table 39. Global Lenvatinib Sales Market Share by Type (2016-2021)
Table 40. Global Lenvatinib Revenue (Million US$) by Type (2016-2021)
Table 41. Global Lenvatinib Revenue Share by Type (2016-2021)
Table 42. Global Lenvatinib Price (US$/Unit) by Type (2016-2021)
Table 43. Global Lenvatinib Sales (K Units) by Application (2016-2021)
Table 44. Global Lenvatinib Sales Market Share by Application (2016-2021)
Table 45. Global Lenvatinib Revenue (Million US$) by Application (2016-2021)
Table 46. Global Lenvatinib Revenue Share by Application (2016-2021)
Table 47. Global Lenvatinib Price (US$/Unit) by Application (2016-2021)
Table 48. Eisai Co. Corporation Information
Table 49. Eisai Co. Description and Business Overview
Table 50. Eisai Co. Lenvatinib Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Eisai Co. Lenvatinib Product
Table 52. Eisai Co. Recent Developments/Updates
Table 53. Beacon Pharmaceuticals Limited Corporation Information
Table 54. Beacon Pharmaceuticals Limited Description and Business Overview
Table 55. Beacon Pharmaceuticals Limited Lenvatinib Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Beacon Pharmaceuticals Limited Lenvatinib Product
Table 57. Beacon Pharmaceuticals Limited Recent Developments/Updates
Table 58. Shilpa Medicare Ltd. Corporation Information
Table 59. Shilpa Medicare Ltd. Description and Business Overview
Table 60. Shilpa Medicare Ltd. Lenvatinib Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Shilpa Medicare Ltd. Lenvatinib Product
Table 62. Shilpa Medicare Ltd. Recent Developments/Updates
Table 63. Everest Medicines Corporation Information
Table 64. Everest Medicines Description and Business Overview
Table 65. Everest Medicines Lenvatinib Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. Everest Medicines Lenvatinib Product
Table 67. Everest Medicines Recent Developments/Updates
Table 68. Production Base and Market Concentration Rate of Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Lenvatinib Distributors List
Table 71. Lenvatinib Customers List
Table 72. Lenvatinib Market Trends
Table 73. Lenvatinib Growth Drivers
Table 74. Lenvatinib Market Restraints
Table 75. Global Lenvatinib Sales Forecast by Type (2022-2027) & (K Units)
Table 76. Global Lenvatinib Sales Market Share Forecast by Type (2022-2027)
Table 77. Global Lenvatinib Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 78. Global Lenvatinib Revenue Market Share Forecast by Type (2022-2027)
Table 79. Global Lenvatinib Sales Forecast by Application (2022-2027) & (K Units)
Table 80. Global Lenvatinib Sales Market Share Forecast by Application (2022-2027)
Table 81. Global Lenvatinib Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 82. Global Lenvatinib Revenue Market Share Forecast by Application (2022-2027)
Table 83. Global Lenvatinib Sales Forecast by Region (2022-2027) & (K Units)
Table 84. Global Lenvatinib Sales Market Share Forecast by Region (2022-2027)
Table 85. Global Lenvatinib Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 86. Global Lenvatinib Revenue Market Share Forecast by Region (2022-2027)
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Lenvatinib
Figure 2. Global Lenvatinib Market Share by Type in 2020 & 2027
Figure 3. 4mg Product Picture
Figure 4. 10mg Product Picture
Figure 5. Global Lenvatinib Market Share by Application in 2020 & 2027
Figure 6. Hospital
Figure 7. Pharmacy
Figure 8. Other
Figure 9. Global Lenvatinib Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Lenvatinib Market Size 2016-2027 (US$ Million)
Figure 11. Global Lenvatinib Sales 2016-2027 (K Units)
Figure 12. Global Lenvatinib Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. Lenvatinib Sales Share by Manufacturers in 2020
Figure 14. Global Lenvatinib Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Lenvatinib Players: Market Share by Revenue in 2020
Figure 16. Lenvatinib Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global Lenvatinib Sales Market Share by Region (2016-2021)
Figure 18. Global Lenvatinib Sales Market Share by Region in 2020
Figure 19. Global Lenvatinib Revenue Market Share by Region (2016-2021)
Figure 20. Global Lenvatinib Revenue Market Share by Region in 2020
Figure 21. U.S. Lenvatinib Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada Lenvatinib Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany Lenvatinib Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France Lenvatinib Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. Lenvatinib Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy Lenvatinib Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia Lenvatinib Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China Lenvatinib Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan Lenvatinib Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea Lenvatinib Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India Lenvatinib Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia Lenvatinib Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Taiwan Lenvatinib Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia Lenvatinib Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand Lenvatinib Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia Lenvatinib Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Philippines Lenvatinib Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Vietnam Lenvatinib Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Mexico Lenvatinib Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Brazil Lenvatinib Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Argentina Lenvatinib Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Turkey Lenvatinib Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Saudi Arabia Lenvatinib Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. UAE Lenvatinib Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Sales Market Share of Lenvatinib by Type (2016-2021)
Figure 46. Sales Market Share of Lenvatinib by Application (2016-2021)
Figure 47. Sales Market Share of Lenvatinib by Application in 2020
Figure 48. Revenue Share of Lenvatinib by Application (2016-2021)
Figure 49. Revenue Share of Lenvatinib by Application in 2020
Figure 50. Manufacturing Cost Structure of Lenvatinib
Figure 51. Manufacturing Process Analysis of Lenvatinib
Figure 52. Lenvatinib Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’